{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:34:58Z","timestamp":1773084898117,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Indian Institute of Technology (IIT), Delhi, IndiaIndian Institute of Technology (IIT), Delhi, India"},{"name":"Central Research Institute, Kasauli (HP), India"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.vaccine.2015.08.076","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T19:01:33Z","timestamp":1441393293000},"page":"5623-5632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system"],"prefix":"10.1016","volume":"33","author":[{"given":"Vivek","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.","family":"Brahmne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2015.08.076_bib0140","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","article-title":"The global impact of vaccines containing aluminium adjuvants","volume":"20","author":"Clements","year":"2002","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2015.08.076_bib0145","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines \u2013 US perspective","volume":"31","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0150","series-title":"Diphtheria toxoid","author":"Mortimer","year":"1999"},{"issue":"17","key":"10.1016\/j.vaccine.2015.08.076_bib0155","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.2174\/092986711795933740","article-title":"Aluminum vaccine adjuvants: are they safe?","volume":"18","author":"Tomljenovic","year":"2011","journal-title":"Curr Med Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2015.08.076_bib0160","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1023\/A:1018942118148","article-title":"Determinants of release rate of tetanus vaccine from polyester microspheres","volume":"10","author":"Alonso","year":"1993","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.vaccine.2015.08.076_bib0165","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/mp800027f","article-title":"Stabilization of tetanus toxoid encapsulated in PLGA microspheres","volume":"5","author":"Jiang","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0170","first-page":"937","article-title":"Fabrication of nanoadjuvant with poly-epsilon-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity","volume":"9","author":"Prashant","year":"2014","journal-title":"Int J Nanomed"},{"issue":"6","key":"10.1016\/j.vaccine.2015.08.076_bib0175","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/02652040110055261","article-title":"Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid","volume":"18","author":"Raghuvanshi","year":"2001","journal-title":"J Microencapsul"},{"issue":"3","key":"10.1016\/j.vaccine.2015.08.076_bib0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.08.076_bib0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijpharm.2014.05.061","article-title":"Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy","volume":"471","author":"Bansal","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymeth.2005.11.003","article-title":"Diphtheria toxoid loaded poly-(\u025b-caprolactone) nanoparticles as mucosal vaccine delivery systems","volume":"38","author":"Singh","year":"2006","journal-title":"Methods"},{"issue":"17","key":"10.1016\/j.vaccine.2015.08.076_bib0195","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.vaccine.2006.01.066","article-title":"Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum","volume":"24","author":"Katare","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0200","first-page":"2443","volume":"III","year":"2010"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0205","series-title":"Technical report series 800","author":"World Health Organisation","year":"1990"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0210","first-page":"505","article-title":"In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model","volume":"8","author":"Tomar","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0215","first-page":"2981","article-title":"Synthesis of biocompatible poly (\u025b-caprolactone)-block-poly (propylene adipate) copolymers appropriate for drug nano encapsulation in the form of core\u2013shell nanoparticles","volume":"6","author":"Nanaki","year":"2011","journal-title":"Int J Nanomed"},{"issue":"4","key":"10.1016\/j.vaccine.2015.08.076_bib0220","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/bja\/78.4.372","article-title":"Increase in serum creatine phosphokinase concentrations after suxamethonium during sevoflurane or isoflurane anaesthesia in children","volume":"78","author":"Kudoh","year":"1997","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.vaccine.2015.08.076_bib0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4103\/0255-0857.37337","article-title":"Typhoid myopathy or typhoid hepatitis: a matter of debate","volume":"25","author":"Mirsadraee","year":"2007","journal-title":"Indian J Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.08.076_bib0230","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0095-4543(05)70347-X","article-title":"Evaluation of tests used to screen patients with liver disorders","volume":"23","author":"Scheig","year":"1996","journal-title":"Prim Care"},{"issue":"2","key":"10.1016\/j.vaccine.2015.08.076_bib0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/rtph.1998.1201","article-title":"Serum transaminase elevations as indicators of hepatic injury following the administration of drugs","volume":"27","author":"Amacher","year":"1998","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.08.076_bib0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2478\/v10102-012-0022-5","article-title":"Evaluation of biochemical, hematological and oxidative parameters in mice exposed to the herbicide glyphosate-Roundup((R))","volume":"5","author":"Jasper","year":"2012","journal-title":"Interdiscip Toxicol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.08.076_bib0245","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants \u2013 a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2015.08.076_bib0250","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1089\/aid.1992.8.1427","article-title":"Summary Adjuvants\/Clinical Trials Working Group","volume":"8","author":"Alving","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"10.1016\/j.vaccine.2015.08.076_bib0255","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2015.08.076_bib0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/14760584.4.2.185","article-title":"Nanoparticles as carriers for nasal vaccine delivery","volume":"4","author":"Koping-Hoggard","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2015.08.076_bib0265","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1163\/156856297X00380","article-title":"Protein release from poly(\u025b-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study","volume":"8","author":"Jameela","year":"1997","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.vaccine.2015.08.076_bib0270","series-title":"Manual for the production and control of vaccines \u2013 tetanus toxoid, BLG\/UNDP\/77.2 Rev.1","author":"World Health Organisation","year":"1977"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15012293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15012293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:12:39Z","timestamp":1556349159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15012293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0264410X15012293"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}